Mechanisms of bone metastasis.
Roodman
G David
GD
Department of Medicine, Division of Hematology-Oncology, University of Pittsburgh, School of Medicine/Hematology, the University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USA. roodmangd@msx.upmc.edu
D014408:Biomarkers, Tumor / Q000032:analysis; D001859:Bone Neoplasms / Q000503:physiopathology / Q000556:secondary*; D016723:Bone Remodeling / Q000502:physiology*; D001943:Breast Neoplasms / Q000473:pathology; D002352:Carrier Proteins / Q000378:metabolism; D005260:Female; D006801:Humans; D008297:Male; D008562:Membrane Glycoproteins / Q000378:metabolism; D009362:Neoplasm Metastasis / Q000175:diagnosis / Q000503:physiopathology; D010006:Osteoblasts / Q000502:physiology; D010010:Osteoclasts / Q000502:physiology; D010014:Osteolysis / Q000503:physiopathology; D011471:Prostatic Neoplasms / Q000473:pathology; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B
D014408:Biomarkers, Tumor; D002352:Carrier Proteins; D008562:Membrane Glycoproteins; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B; C505686:TNFRSF11A protein, human; C505688:TNFSF11 protein, human